CVS HEALTH CORPORATION— Sankey Diagram
Annual mode · period ending 2025-12-31 · SEC EDGAR
FY2025 - Q4(Oct 25 · Nov 25 · Dec 25)
Total Assets
$253.54B
↑+0.1% +$323Mvs FY2024
Total Liabilities
$178.16B
↑+0.4% +$671Mvs FY2024
Equity
$75.21B
↓-0.5% -$346Mvs FY2024
Cash
$8.45B
↓-1.5% -$133Mvs FY2024
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $253.54B | $253.22B |
| Current Assets | $74.71B | $68.64B |
| Cash | $8.45B | $8.59B |
| ST Investments | $2.15B | $2.41B |
| Receivables | $39.78B | $36.47B |
| Inventory | $19.25B | $18.11B |
| Other Current | $5.09B | $3.08B |
| Non-Current Assets | $178.82B | $184.57B |
| PPE | $0 | $0 |
| Goodwill | $85.48B | $91.27B |
| Intangibles | $25.51B | $27.32B |
| Investments | $32.67B | $28.93B |
| Other Non-Current | $35.17B | $37.04B |
| Total Liab+Eq | $253.37B | $253.04B |
| Current Liab. | $88.69B | $84.61B |
| Accounts Payable | $0 | $0 |
| Short-Term Debt | $0 | $2.12B |
| Deferred Revenue | $62M | $144M |
| Other CL | $88.63B | $82.35B |
| Non-Current Liab. | $89.46B | $92.88B |
| Long-Term Debt | $0 | $0 |
| Other LT Liab. | $89.46B | $92.88B |
| Equity | $75.21B | $75.56B |
| Retained Earnings | $61.20B | $62.84B |
| Other Equity | $14.02B | $12.72B |
QuarterCharts · SEC EDGAR data · CVS · Comparing FY2025 vs FY2024